Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1/2 carrier cohort (GENEPSO).

Julie Lecarpentier 1 Catherine Noguès 2 Emmanuelle Mouret-Fourme 2 Marion Gauthier-Villars 3 Christine Lasset 4, 5 Jean-Pierre Fricker 6 Olivier Caron 7 Dominique Stoppa-Lyonnet 3, 8 Pascaline Berthet 9 Laurence Faivre 10, 11 Valérie Bonadona 5, 4 Bruno Buecher 3 Isabelle Coupier 12, 13 Laurence Gladieff 14 Paul Gesta 15 François Eisinger 16, 17 Marc Frénay 18 Elisabeth Luporsi 19 Alain Lortholary 20 Chrystelle Colas 21 Catherine Dugast 22 Michel Longy 23 Pascal Pujol 12 Julie Tinat 24 Rosette Lidereau 25 Nadine Andrieu 1, *
Abstract : ABSTRACT: INTRODUCTION: Mutations in BRCA1 and BRCA2 confer a high risk of breast cancer (BC), but the magnitude of this risk seems to vary according to the study and various factors. Although controversial, there are data to support the hypothesis of allelic risk heterogeneity. METHODS: We assessed variation in BC risk according to factors related to pregnancies by location of mutation in homogeneous risk region of BRCA1 and BRCA2 in 990 women of the French study GENEPSO by using a weighted Cox regression model. RESULTS: Our results confirm the existence of a protective effect of an increasing number of full-term pregnancies (FTPs) toward BC among BRCA1 and BRCA2 mutation carriers ([greater than or equal to]3 vs. 0 FTPs: HR=0.51, 95% CI=0.33-0.81). Additionally, hazard ratio (HR) show an association between incomplete pregnancies and a higher BC risk, which reached 2.39 (95% CI=1.28-4.45) among women who had at least three incomplete pregnancies when compared with women with zero incomplete pregnancies. This increased risk appeared to be restricted to incomplete pregnancies occurring before the first FTP (HR=1.77, 95% CI=1.19-2.63). We defined the TMAP score (defined as the Time of breast Mitotic Activity during Pregnancies) to take into account simultaneously the opposite effect of full-term and interrupted pregnancies. Compared with women with a TMAP score of less than 0.35, an increasing TMAP score was associated with a statistically significant increase in the risk of BC (P trend=0.02) which reached 1.97 (95% CI=1.19-3.29) for a TMAP score > 0.5 (vs. TMAP less than or equal to 0.35). All these results appeared to be similar in BRCA1 and BRCA2. Nevertheless, our results suggest a variation in BC risk associated with parity according to the location of the mutation in BRCA1. Indeed, parity seems to be associated with a significantly decreased risk of BC only among women with a mutation in the central region of BRCA1 (low-risk region) (greater than or equal to 1 vs. 0 FTP: HR=0.27, 95% CI=0.13-0.55) (pinteraction <10-3). CONCLUSION: Our findings show that, taking into account environmental and lifestyle modifiers, mutation position might be important for the clinical management of BRCA1 and BRCA2 mutation carriers and could also be helpful in understanding how BRCA1 and BRCA2 genes are involved in BC.
Type de document :
Article dans une revue
Breast Cancer Research, BioMed Central, 2012, 14 (4), pp.R99. 〈10.1186/bcr3218〉
Liste complète des métadonnées

Littérature citée [60 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00724092
Contributeur : Ed. Bmc <>
Soumis le : vendredi 17 août 2012 - 13:05:39
Dernière modification le : jeudi 8 février 2018 - 11:08:37
Document(s) archivé(s) le : dimanche 18 novembre 2012 - 02:30:19

Fichiers

bcr3218.pdf
Fichiers éditeurs autorisés sur une archive ouverte

Identifiants

Citation

Julie Lecarpentier, Catherine Noguès, Emmanuelle Mouret-Fourme, Marion Gauthier-Villars, Christine Lasset, et al.. Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1/2 carrier cohort (GENEPSO).. Breast Cancer Research, BioMed Central, 2012, 14 (4), pp.R99. 〈10.1186/bcr3218〉. 〈inserm-00724092〉

Partager

Métriques

Consultations de la notice

1074

Téléchargements de fichiers

951